VEELBORE 3.5 mg Powder For Solution For Injection 3.5 mg powder for solution for injection 8ml Vial

VEELBORE 3.5 mg Powder For Solution For Injection is a specialized pharmaceutical product containing Lanreotide. For professional pharmaceutical details and availability, refer to trusted sources like , and in some regions, general e-commerce platforms such as or may list related products.

Product Description

VEELBORE 3.5 mg Powder For Solution For Injection is a specialized pharmaceutical product containing Lanreotide.

Lanreotide is a synthetic analog of somatostatin, a naturally occurring hormone that inhibits the secretion of various other hormones.

This medication is designed for subcutaneous or deep intramuscular administration following reconstitution from its powder form.

It is primarily used in the management of specific endocrine and oncology conditions where hormone overproduction or tumor growth needs to be controlled.

Benefits of Use

VEELBORE (Lanreotide) offers significant therapeutic advantages for patients suffering from particular medical conditions.

It is highly effective in treating Acromegaly, a disorder caused by excessive growth hormone production, by reducing growth hormone (GH) and insulin-like growth factor-1 (IGF-1) levels.

It is also indicated for the treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NETs), helping to control tumor growth and manage symptoms associated with hormone overproduction, such as carcinoid syndrome.

The medication helps to improve the quality of life for patients by alleviating symptoms like diarrhea, flushing, and abdominal pain associated with these conditions.

How to Use

1. Ensure all necessary equipment is sterile, including the vial of powder, diluent, and syringe.
2. Reconstitute the powder for injection using the specified diluent volume as per the package leaflet.
3. Gently swirl the vial until the powder is completely dissolved, ensuring no particulate matter remains.
4. Do not shake the vial vigorously, as this may cause foaming.
5. Draw the reconstituted solution into the syringe immediately after preparation.
6. Administer the solution via deep subcutaneous or intramuscular injection as prescribed by your doctor.
7. The injection site should be rotated to avoid lipodystrophy.
8. Follow the prescribed dosage and administration schedule strictly for optimal therapeutic outcomes.

Caution & Warnings

• Inform your doctor about all existing medical conditions, especially diabetes, gallbladder disease, or heart problems, before starting treatment.
• Monitor blood glucose levels regularly, as Lanreotide can affect glucose metabolism, potentially requiring adjustment of antidiabetic medication.
• Gallstones may develop or worsen during treatment with Lanreotide; monitor for symptoms and consult your doctor.
• Exercise caution in patients with cardiac bradycardia as Lanreotide may cause or exacerbate this condition.
• This medication may interact with other drugs; always disclose all current medications, including over-the-counter drugs and herbal supplements, to your healthcare provider.
• Pregnant or breastfeeding women should consult their doctor before using this medication, as its effects on fetal development or infant health are not fully established.
• Do not use if the powder or reconstituted solution appears discolored or contains foreign particles.

Ingredients

Active Ingredient: Lanreotide 3.5 mg

Other Ingredients: (Specific excipients are typically detailed in the package leaflet; please refer to the product packaging for a complete list of inactive ingredients.)

Product Details

Form: Powder for solution for injection

Strength: 3.5 mg

Package Size: 1 Vial

Manufacturer: Ipsen Pharma